Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 193551-21-2 | Product Number: B5898
SB 239063
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- trans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexanol
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5MG |
€124.00
|
Contact Us | 11 |
|
| 25MG |
€454.00
|
Contact Us | 38 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | B5898 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__2__1FN__4O__2 = 368.41 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 193551-21-2 |
| Reaxys Registry Number | 9010076 |
| PubChem Substance ID | 468590774 |
| MDL Number | MFCD03792786 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 207 °C |
GHS
Related Laws:
| RTECS# | GV9458000 |
Transport Information:
| HS Number | 2933599590 |
Application
SB 239063: A Selective p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor
SSB 239063 is a selective p38 mitogen-activated protein kinase (MAPK) inhibitor. It displays greater than 220-fold selectivity for p38 MAPK over other kinases.1) The p38 MAPK has been linked to inflammatory cytokine production and cell death in cellular stress. SB 239063 has been shown to reduce inflammatory cytokine production.1-4)
References
- 1) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence
- 2) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
- 3) Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia (a review)
- 4) SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.